Empagliflozin/Metformin Film-Coated Tablets 5/1000 mg
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
MFDS item code 202201339 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication contains both empagliflozin and metformin, effectively assisting adults with type 2 diabetes in controlling their blood sugar when combined with diet and exercise. It is particularly suitable for those whose blood sugar is not sufficiently controlled, and those with cardiovascular disease should use it according to a specialist's guidance. This medication is used to improve blood sugar management and support diabetes treatment.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. No dose adjustment is required for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately. In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication is used to help lower blood sugar levels in diabetic patients. When taking this medication, there is a risk of rare side effects such as serious lactic acidosis, so caution is necessary. In addition, using this medication with other diabetes drugs like insulin or sulfonylureas may increase the risk of hypoglycemia, so care is needed. This medication should not be used in patients with significant renal impairment, acute renal issues, severe infections, heart failure, or type 1 diabetes. If an iodinated contrast agent for radiological examinations is planned, temporarily discontinue this medication before and after the test. Patients about to undergo surgery should also stop taking this medication 48 hours prior and resume only when their kidney function returns to normal. Patients with poor liver function, severe pulmonary diseases, or excessive alcohol consumption should avoid this medication. Pregnant or breastfeeding women should not take this medication, and those breastfeeding are advised to discontinue use. Regular monitoring of kidney function and serum creatinine levels is necessary during treatment. This medication may increase urination, and the risk of urinary tract infections or genital infections may climb, so consult a doctor immediately if symptoms of infection appear. Hypotension or dehydration due to fluid loss can occur, hence caution is needed in cases of dehydration symptoms or reduced fluid volume risk. Vitamin B12 levels may decrease, so patients taking this medication long-term should regularly check their Vitamin B12 levels. Hypoglycemia symptoms may occur, so especially when taken with other hypoglycemic agents, blood sugar changes should be carefully monitored. Alcohol can increase the risk of lactic acidosis, hence excess drinking should be avoided while on this medication. If pain, swelling, or redness occurs around the genital area during the course of treatment, inform healthcare providers immediately as there may be a serious infection like perineal necrosis. Elderly patients or those with poor kidney function may need dose adjustments and regular testing; it is safe to stay within the maximum prescribed dose. In case of an overdose, serious side effects may appear, so take the exact dose as prescribed by a physician and receive appropriate treatment at a hospital if necessary. This medication is not recommended for children and it is advisable not to use it for individuals under 18 years old.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius. This will help retain the medication's effectiveness and safety.
Biconvex oval film-coated tablet, yellow with a brown tint
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.